OCUL vs ONC Stock Comparison

ONC currently leads OCUL in this stock comparison, with AIQ scores of 80 vs 38. The clearest difference is momentum.

Market data as of Nov 15, 2026 market close· AIQ score gap 42 points
OCUL
Healthcare
vs
ONC
Healthcare
OCUL
Ocular Therapeutix, Inc.
Price
$6.21
Day move
-1.11%
AIQ Score
38/100
Best edge
Balanced
Sector
Healthcare
ONC
BeOne Medicines AG
Leads
Price
$417
Day move
+0.14%
AIQ Score
80/100
Best edge
Momentum
Sector
Healthcare

What is the main difference between OCUL and ONC?

ONC leads the current stock comparison as BeOne Medicines AG, with the clearest separation coming from momentum and the broader AIQ evidence mix.

AlgovestIQ AIQ Comparison

Ocular Therapeutix, Inc. vs BeOne Medicines AG

Data as of Nov 15, 2026· market close· Healthcare· Coverage 64/66 fields· High confidence
AIQ VerdictStableAIQ Comparison Conviction 9/10

ONC leads

ONC leads by 42 AIQ points, primarily on Momentum and Quality, and the lead has widened from 32 points over 30 sessions. Wall Street currently favors OCUL on target upside.

Stable: 5 of 6 evidence groups support ONC, its lead is widening, and its current signal state is conflicted.

Evidence agreement: 5 of 6Comparison trend: Strengthening
OCUL

Ocular Therapeutix, Inc.

AIQ Score
38/100
AIQ Edge Score
1/10
ONC

BeOne Medicines AG

Leads
AIQ Score
80/100
AIQ Edge Score
10/10

The Algovestiq AIQ Score currently favors ONC over OCUL, 80 versus 38 as of Nov 15, 2026. ONC's advantage is driven primarily by stronger momentum and quality. ONC also shows the stronger technical structure relative to its 50-day moving average, though analyst target upside currently favors OCUL. 5 of 6 covered evidence groups favor ONC today, and the comparison is rated Stable on stability: the leader is throwing conflicting signals. ONC lead: Strengthening — the AIQ differential moved from 32 to 42 points over 30 sessions. ONC leads on all four AIQ factor dimensions. Value is itself one of those four, so a sweep is not explained by valuation alone — it deserves additional scrutiny for unmodeled catalysts, expectations or event risk.

Compare Ocular Therapeutix, Inc. and BeOne Medicines AG across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.

Currently unavailable

Performance over time

Price return from daily closes; distributions are not included.

OCUL
-28.9%
ONC
+126.4%

Price return comparison

Growth of $10,000, price only

OCUL $7,105 · ONC $22,638

Split-adjusted closes only. Distributions are excluded, which understates the return of any fund or stock that pays them.

Compare OCUL and ONC against another ticker

Open a multi-ticker workspace without changing this focused pair page.

Basic: 2 symbols·Explorer: 3 symbols·Pro and Premium: 5 symbols·Your limit: 2

AIQ Factor Divergence

Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.

OCUL advantage
0
ONC advantage
  • Momentum34 vs 91
    ONC +57
  • Quality42 vs 78
    ONC +36
  • Risk Resilience36 vs 72
    ONC +36
  • Value41 vs 71
    ONC +30

5 of 6 evidence groups favor ONC. ONC’s edge is concentrated in momentum and quality.

What changed since the last close

Latest scored session 2026-11-13, compared against the prior scored session 2026-11-12.

OCUL0 AIQ

Largest factor move: Momentum -1, not enough on its own to move the overall score.

New signals

  • 52-Week Low Proximity — bearish, risk_regime, long horizon (0.0%)
ONC0 AIQ

Largest factor move: Value +1, not enough on its own to move the overall score.

No signal started or stopped since the prior session; its 7 active signals are unchanged.

ONC's lead was unchanged in the latest session.

Deeper signal detail for each name lives on its own signals page — OCUL and ONC both carry a full feed there.

The central trade-off

ONC (BeOne Medicines AG): the stronger current systematic profile, led by momentum and quality.

OCUL (Ocular Therapeutix, Inc.): the counter-case, on analyst expectations — but at materially higher volatility, 75.1% against 38.6%.

The AIQ Score and Wall Street therefore point in different directions on this pair.

Which one fits your objective

The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.

Balanced

ONC

ONC on the overall AIQ Score, which weights Quality and Value most heavily.

Growth

OCUL

OCUL on combined revenue and EPS growth.

Value

ONC

ONC on the peer-relative Value factor, by 30 points.

Momentum

ONC

ONC on the Momentum factor, by 57 points.

Lower downside

ONC

ONC on Risk Resilience, by 36 points.

Analyst upside

OCUL

OCUL on implied upside to the consensus price target.

AIQ vs Wall Street

The model and the Street disagree here: AIQ favors ONC, analyst targets favor OCUL. That disagreement is the most useful thing on this page.

MeasureOCULONCNote
Implied upside to target+125.4%+5.1%OCUL has more room
Target dispersion0%+12.6%Lower is tighter analyst agreement
ConsensusBuyBuyContext, not a primary driver
Analysts covering1227Higher coverage generally improves confidence

The two are measuring different things. The AIQ Score reads current fundamentals, valuation, trend and risk; analyst targets price forward expectations. A divergence of this kind is either a contrarian opportunity or a sign the model is missing something already priced in — it is worth resolving before acting on either.

Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.

AIQ Agreement Matrix

5 of 6 covered evidence groups favor ONC. A wide gap backed by one group is a weaker case than a narrow gap backed by five.

Evidence groupFavorsReading
AIQ ScoreONC38 vs 80
FundamentalsONCon balancerevenue growth -4.5% vs 10.8%; EPS growth -20% vs -87.5%; TTM ROE -21.5% vs 6.6%; gross margin 87.3% vs 88.4%; operating margin -6.8% vs 17.8% — ONC takes 4 of 5 decided legs, not all of them
ValuationONCValue 41 vs 71
TechnicalsONCPrice vs 50-day -22.3% vs 12.8%; vs 200-day -30.3% vs 27.1%
Risk ResilienceONCRisk Resilience 36 vs 72
Analyst expectationsOCULTarget upside 125.4% vs 5.1%

✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of OCUL and ONC and are excluded from the count.

AIQ Decision Stability

Stable

The conclusion rests on a wide gap and broad agreement. It is unlikely to turn on a single session.

  • The AIQ gap is wide at 42 points. (supports the conclusion holding)
  • 5 of 6 covered evidence groups point the same way. (supports the conclusion holding)
  • The leader's advantage has been widening. (supports the conclusion holding)
  • The lead has been steady session to session. (supports the conclusion holding)
  • The leader is throwing conflicting signals. (argues the conclusion is provisional)

Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on ONC.

How the comparison changed

120 daily snapshots · May 27 – Nov 13

ONC lead: Strengthening — the AIQ differential moved from 32 to 42 points over 30 sessions.

May 27OCUL leads above the line · ONC leads belowNov 13
Today
ONC +42
38 vs 80
7 sessions ago
ONC +37
41 vs 78
30 sessions ago
ONC +32
44 vs 76
90 sessions ago
ONC +22
47 vs 69

The lead has not changed hands in this window.

AIQ Signal Divergence

Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.

OCUL

0 bullish / 4 bearish / 2 neutral

Only OCUL

  • Death Cross Active — bearish, trend, long horizon (11.42%)
  • 52-Week Low Proximity — bearish, risk_regime, long horizon (0.0%)
  • ADX Trend Strengthening — neutral, trend, medium horizon
  • ATR Expansion - Breakout Mode — neutral, volatility, short horizon (7.28%)
  • Beta Spike Warning — bearish, risk_regime, long horizon
  • Downtrend Structure Active — bearish, trend, long horizon
ONCConflicted

6 bullish / 1 bearish, conflicted

Only ONC

  • Golden Cross Active — bullish, trend, long horizon (12.62%)
  • 52-Week High Proximity — bullish, risk_regime, long horizon (1.8%)
  • EMA Ribbon Expansion Bullish — bullish, trend, medium horizon
  • Keltner Channel Breakout — bullish, volatility, short horizon
  • Low Volume Rally Warning — bearish, volume, short horizon (0.74x)
  • TRIX Bullish Signal — bullish, momentum, short horizon
  • Uptrend Structure Active — bullish, trend, long horizon

ONC leads the comparison while carrying a conflicted signal state, which is one reason the stability rating is not higher.

Price vs model alignment

Whether the latest session's price move confirms what the model did over the same session, or contradicts it.

OCULNo material change

Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price -1.11%, AIQ 0 points).

ONCNo material change

Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price +0.14%, AIQ 0 points).

What would flip this result

A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.

  1. 1OCUL closes the Momentum gap — currently 57 points behind, the largest single contributor to ONC's edge.
  2. 2OCUL's Death Cross Active resolves — a bearish trend rule currently active against it.
  3. 3ONC's conflicting signal state resolves bearish — it currently carries 6 bullish and 1 bearish rules at once.
  4. 4A market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.

The full evidence

Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.

Fundamentals

ONC leads on balance
MetricOCULONC
Revenue growth (YoY)-4.5%10.8%
EPS growth (YoY)-20%-87.5%
Gross margin87.3%88.4%
Operating margin-6.8%17.8%
Return on equity (TTM)-21.5%6.6%
Debt to equity0.180.2

Performance

ONC leads 6 of 6 windows
MetricOCULONC
1 week (5 sessions)-5.8%2.4%
1 month (20 sessions)-9.6%12.9%
3 months (63 sessions)-41.7%14.9%
6 months (126 sessions)-32.2%42%
Year to date-48.8%37.1%
1 year (252 sessions)-46%10.4%

Technicals

ONC has the stronger structure
MetricOCULONC
RSI (14)37.667.5
ADX (14)40.419.8
Price vs 50-day-22.3%12.8%
Price vs 200-day-30.3%27.1%
Volatility (1M, annualized)75.1%38.6%

Risk

ONC is the more resilient
MetricOCULONC
Beta1.390.68
Sharpe ratio-0.450.42
Sortino ratio-0.670.62
Max drawdown-61.5%-30.9%
Current drawdown-61.5%-1.8%
Annualized volatility76.1%34.2%
Value at risk (95%)-6.7%-3%

Straight answers

Each answer is regenerated from the current snapshot, not written once and left to age.

Which is better, OCUL or ONC?

On the Algovestiq AIQ Score, ONC is the stronger of the two as of Nov 15, 2026, scoring 80 against OCUL's 38. The edge comes from momentum and quality. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.

Is OCUL or ONC the better buy right now?

ONC carries the stronger systematic profile as of Nov 15, 2026, and the comparison is rated Stable — 5 of 6 covered evidence groups agree. A Stable rating means the gap is wide and the evidence is broad, so the conclusion is unlikely to turn on a single session.

Why does the AIQ Score favor ONC over OCUL?

The composite weights Quality, Value, Momentum and Risk Resilience. ONC leads Momentum by 57 points; ONC leads Quality by 36 points; ONC leads Risk Resilience by 36 points. ONC leads on all four AIQ factor dimensions. Value is itself one of those four, so the sweep is not explained by OCUL simply being cheaper — it warrants extra scrutiny for unmodeled catalysts, forward expectations or event risk the factors do not capture.

Which has more analyst upside, OCUL or ONC?

Analyst price targets imply +125.4% upside for OCUL and +5.1% for ONC, so the Street currently favors OCUL. That points the opposite way to the AIQ Score, which favors ONC. The two are measuring different things: the model reads current fundamentals, valuation, trend and risk; the Street is pricing forward expectations. A divergence of this kind is either a contrarian opportunity or a sign the model is missing something the analysts have already priced — it is the single most useful row on this page to investigate. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.

Which is better value, OCUL or ONC?

ONC is the better-valued of the two on the peer-relative Value factor. ONC on the peer-relative Value factor, by 30 points. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.

Which has stronger growth, OCUL or ONC?

OCUL on combined revenue and EPS growth. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.

Which has stronger momentum, OCUL or ONC?

ONC on the Momentum factor, by 57 points. Momentum is one of the four weighted factors in the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.

Which is riskier, OCUL or ONC?

ONC is the more resilient of the two, so the other name carries the higher downside risk. ONC on Risk Resilience, by 36 points. Risk Resilience is a weighted factor in the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.

Is OCUL more profitable than ONC?

ONC leads on the comparable margin measures — gross margin 87.3% vs 88.4%; operating margin -6.8% vs 17.8%; ttm roe -21.5% vs 6.6%.

Is ONC's lead over OCUL getting stronger or weaker?

ONC lead: Strengthening — the AIQ differential moved from 32 to 42 points over 30 sessions. This is measured from 120 daily comparison snapshots between 2026-05-27 and 2026-11-13. The lead has not changed hands in that window.

What would change the OCUL vs ONC verdict?

The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: OCUL closes the Momentum gap — currently 57 points behind, the largest single contributor to ONC's edge; OCUL's Death Cross Active resolves — a bearish trend rule currently active against it; ONC's conflicting signal state resolves bearish — it currently carries 6 bullish and 1 bearish rules at once; a market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.

What do the current signals say about OCUL and ONC?

OCUL: 0 bullish / 4 bearish / 2 neutral. ONC: 6 bullish / 1 bearish, conflicted. A conflicted state means bullish and bearish rules are active on the same name at once — the technical evidence is not pointing one way, and a decision taken on it carries more timing risk. The most decision-relevant rule on OCUL is Death Cross Active (bearish, long horizon). On ONC it is Golden Cross Active (bullish, long horizon).

Compare OCUL and ONC with others

Continue your research

This page answers which of the two. These answer the questions on either side of it.

How this comparison is scored

The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.

The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.

How to use side-by-side comparison →

This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.